Subscribe today to receive notice of our latest thought leadership, articles, blogs and updates.
Insights
Blogs
Sharing perspectives leads to greater understanding and fuels innovation
Check out our latest blog posts:
|
July 28, 2022 · Public Policy & Regulatory Affairs Team
Read more... |
|
July 14, 2022 · Clinical Team
Effective June 30, 2022, Zelnorm 6 mg tablet will no longer be produced and marketed in the United States, as announced by its manufacturer, Alfasigma USA, Inc. Read more... |
|
July 06, 2022 · Clinical Team
The U.S. Food and Drug Administration (FDA) approved Quviviq (daridorexant) 25 mg and 50 mg tablets on January 10, 2022. Manufactured by Idorsia Pharmaceuticals US Inc., this sedative/hypnotic is indicated for the treatment of adults with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance. Read more... |
|
June 23, 2022 · Public Policy & Regulatory Affairs Team
Read more... |
|
|
May 31, 2022 · Public Policy & Regulatory Affairs Team
Read more... |
|
|
May 10, 2022 · Public Policy & Regulatory Affairs Team
Read more... |
|
|
April 20, 2022 · Public Policy & Regulatory Affairs Team
Read more... |
|
|
March 30, 2022 · Public Policy & Regulatory Affairs Team
Read more... |
|
March 09, 2022 · Public Policy & Regulatory Affairs Team
Read more... |
|
|
February 17, 2022 · Clinical Team
The U.S. Food and Drug Administration (FDA) issued a warning on January 12, 2022, regarding a potential risk of dental problems with orally-dissolving buprenorphine medications. Buprenorphine is a mixed opiate agonist-antagonist used to treat opioid use disorder (OUD) and pain. Read more... |
|
|
February 16, 2022 · Public Policy & Regulatory Affairs Team
Read more... |
|
|
February 10, 2022 · Clinical Team
In October 2021, the U.S. Food and Drug Administration (FDA) approved a higher-dose naloxone hydrochloride (HCl) injection - ZIMHI™ (5 mg/0.5 mL) - to treat opioid analgesic overdose. ZIMHI is designed to be administered in the muscle (intramuscular) or under the skin (subcutaneous) using a single-dose, prefilled syringe that delivers 5 mg of naloxone HCl solution. Read more... |
Page 6 of 7
